Jumpstart Bio: A Short Program on Shorts

Life science, biotech, and technology companies often dominate the list of most shorted stocks with earnings and product announcements, and are frequently hit with short seller reports which usually result in internal dilemmas and disagreement about whether and how to respond. These short sellers often attract activists and other event driven investors who can assert pressure on a Board.

Please join Goodwin partners Caroline Bullerjahn and Joe Johnson, and Andrea Rose, a partner at Joele Frank, as they discuss how to handle negative reports issued by short sellers.